427 related articles for article (PubMed ID: 34419070)
61. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
Yun Z; Meng F; Li S; Zhang P
Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
[TBL] [Abstract][Full Text] [Related]
62. miR-24-3p Regulates Epithelial-Mesenchymal Transition and the Malignant Phenotype of Pancreatic Adenocarcinoma by Regulating ASF1B Expression.
Huang W; Lin T; Huang L; Wu J; Hong J; Qiu F; Tian Y; Wang Y
Biochem Genet; 2023 Apr; 61(2):742-761. PubMed ID: 36114946
[TBL] [Abstract][Full Text] [Related]
63. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
Bhatti I; Lee A; James V; Hall RI; Lund JN; Tufarelli C; Lobo DN; Larvin M
J Gastrointest Surg; 2011 Jan; 15(1):199-208. PubMed ID: 21088996
[TBL] [Abstract][Full Text] [Related]
64. Circular RNA circ_0047744 suppresses the metastasis of pancreatic ductal adenocarcinoma by regulating the miR-21/SOCS5 axis.
Xie H; Zhao Q; Yu L; Lu J; Peng K; Xie N; Ni J; Li B
Biochem Biophys Res Commun; 2022 May; 605():154-161. PubMed ID: 35334414
[TBL] [Abstract][Full Text] [Related]
65. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
66. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis.
Gao S; Cai Y; Zhang H; Hu F; Hou L; Xu Q
J Cell Physiol; 2019 May; 234(5):6746-6757. PubMed ID: 30382579
[TBL] [Abstract][Full Text] [Related]
67. miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2.
Dey S; Kwon JJ; Liu S; Hodge GA; Taleb S; Zimmers TA; Wan J; Kota J
Mol Cancer Res; 2020 Feb; 18(2):311-323. PubMed ID: 31662451
[TBL] [Abstract][Full Text] [Related]
68. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
69. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis.
Huang F; Chen W; Peng J; Li Y; Zhuang Y; Zhu Z; Shao C; Yang W; Yao H; Zhang S
Mol Cancer; 2018 Jul; 17(1):98. PubMed ID: 30001707
[TBL] [Abstract][Full Text] [Related]
70. The loss of miR-26a-mediated post-transcriptional regulation of cyclin E2 in pancreatic cancer cell proliferation and decreased patient survival.
Deng J; He M; Chen L; Chen C; Zheng J; Cai Z
PLoS One; 2013; 8(10):e76450. PubMed ID: 24116110
[TBL] [Abstract][Full Text] [Related]
71. Circular RNA Fibroblast Growth Factor Receptor 1 Promotes Pancreatic Cancer Progression by Targeting MicroRNA-532-3p/PIK3CB Axis.
Wang KQ; Ye ML; Qiao X; Yu ZW; Wu CX; Zheng JF
Pancreas; 2022 Sep; 51(8):930-942. PubMed ID: 36607937
[TBL] [Abstract][Full Text] [Related]
72. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
73. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
Li Z; Yanfang W; Li J; Jiang P; Peng T; Chen K; Zhao X; Zhang Y; Zhen P; Zhu J; Li X
Cancer Lett; 2018 Sep; 432():237-250. PubMed ID: 29709702
[TBL] [Abstract][Full Text] [Related]
74. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC.
Li J; Tong H; Li D; Jiang Q; Zhang Y; Tang W; Jin D; Chen S; Qin X; Zhang S; Xue R
Mol Med; 2021 Aug; 27(1):95. PubMed ID: 34470609
[TBL] [Abstract][Full Text] [Related]
75. MicroRNA-664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma.
Wang Q; Wang J; Niu S; Wang S; Liu Y; Wang X
Int J Oncol; 2019 May; 54(5):1884-1896. PubMed ID: 30896829
[TBL] [Abstract][Full Text] [Related]
76. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
[TBL] [Abstract][Full Text] [Related]
77. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
Huang S; Guo H; Cao Y; Xiong J
Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
[TBL] [Abstract][Full Text] [Related]
78. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract][Full Text] [Related]
79. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract][Full Text] [Related]
80. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis.
Zhu Y; Tian J; Peng X; Wang X; Yang N; Ying P; Wang H; Li B; Li Y; Zhang M; Cai Y; Lu Z; Niu S; Li Y; Zhong R; Chang J; Miao X
Eur J Cancer; 2021 Jul; 151():94-105. PubMed ID: 33975060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
